Side Effects

Edit Content

SIDE EFFECTS

For more detailed information regarding side effects, please refer to the appropriate product monograph.

  • Infusion/injection-related reactions – sometimes can be managed with pre-medications, IV fluids, or lengthening infusion duration.
  • Increased risk of serious infection (sepsis and pneumonia), invasive fungal infections and viral infections; approximately 10% increased risk at wk 54. Reactivation of latent TB.
  • Can worsen pre-existing CHF.
  • Lupus-like reaction (rare).
  • Anti-TNF–induced psoriasis and eczema.
  • Hepatocellular damage, hepatitis, jaundice, autoimmune hepatitis; reactivation of HBV.
  • Potential increased risk of malignancy (lymphoma, hepatosplenic T-cell lymphoma, melanoma, and NMSC); increased frequency when used in combination with a thiopurine.
  • Demyelinating disease – numbness and tingling in legs, arms, etc.
  • Change in vision, weakness in legs, dizziness.
           
Edit Content

SIDE EFFECTS

For more detailed information regarding side effects, please refer to the appropriate product monograph.

  • Infusion/injection-related reactions – sometimes can be managed with pre-medications, IV fluids, or lengthening infusion duration.
  • Increased risk of serious infection (sepsis and pneumonia), invasive fungal infections and viral infections; approximately 10% increased risk at wk 54. Reactivation of latent TB.
  • Can worsen pre-existing CHF.
  • Lupus-like reaction (rare).
  • Anti-TNF–induced psoriasis and eczema.
  • Hepatocellular damage, hepatitis, jaundice, autoimmune hepatitis; reactivation of HBV.
  • Potential increased risk of malignancy (lymphoma, hepatosplenic T-cell lymphoma, melanoma, and NMSC); increased frequency when used in combination with a thiopurine.
  • Demyelinating disease – numbness and tingling in legs, arms, etc.
  • Change in vision, weakness in legs, dizziness.
           
Edit Content

SIDE EFFECTS

For more detailed information regarding side effects, please refer to the appropriate product monograph.

  • Infusion reaction
  • Injection-site reactions
  • Headaches
  • Diarrhea
  • Skin rash or itching
  • Possible infusion reaction
           
Edit Content

SIDE EFFECTS

For more detailed information regarding side effects, please refer to the appropriate product monograph.

  • Nasopharyngitis
  • Arthralgia
  • Headache
  • Nausea
  • Pyrexia
  • Upper respiratory tract infection
  • Fatigue
  • Malignancy
  • Elevated transaminase has been reported
  • No serious infections
           
Edit Content

SIDE EFFECTS

For more detailed information regarding side effects, please refer to the appropriate product monograph.

  • Infusion/injection site–related reactions – sometimes managed with pre-medications.
  • Increased risk of serious infection (sepsis and pneumonia), invasive fungal infections, and viral infections
  • Approximately 10% increased risk at wk 54 Reactivation of latent TB.
  • Can worsen pre-existing CHF
  • Lupus-like reaction (rare)
  • Hepatocellular damage, hepatitis, jaundice, autoimmune hepatitis; reactivation of HBV
  • Potential increased risk of malignancy (lymphoma, hepatosplenic T-cell lymphoma, melanoma, and NMSC); Increased frequency when used in combo with a thiopurine.
  • Numbness and tingling in legs, arms, etc.; change in vision, weakness in legs, dizziness
           
Edit Content

SIDE EFFECTS

For more detailed information regarding side effects, please refer to the appropriate product monograph.

  • Potential viral Infections (e.g., shingles)
  • Potential increased risk of thrombosis
  • Liver enzyme increase
  • GI upset
  • Lipid parameters increase
  • Malignancies: NMSC
  • Potential for increased clots, although was only thus far noted in rheumatoid patients older than age 50 with cardiac risk factors.
           
Edit Content

SIDE EFFECTS

For more detailed information regarding side effects, please refer to the appropriate product monograph.

  • Nasopharyngitis
  • Opportunistic infections
  • Upper respiratory tract infections
  • Herpes zoster
  • CPK elevation
  • Liver enzyme increase
  • Neutropenia
           
Edit Content

SIDE EFFECTS

For more detailed information regarding side effects, please refer to the appropriate product monograph.

  • Infection
  • Macular edema
  • Skin cancer
  • Hepatic infections
  • Decreased HR or atrioventricular delays
  • Crohn’s Colitis Canada website:
    o Higher levels of ALT, nasopharyngitis, and headache
 
           
Edit Content

SIDE EFFECTS

For more detailed information regarding side effects, please refer to the appropriate product monograph.

  • Upper respiratory tract infections
  • Arthralgia
  • Injection-site reactions
  • Rash
  • Headache
  • Hepatotoxicity
  • Herpes viral infection
           
Edit Content

SIDE EFFECTS

For more detailed information regarding side effects, please refer to the appropriate product monograph.

  • Lymphopenia
  • Headache
  • Bradyarrhythmia
  • Infections
  • Elevated hepatic enzymes
  • Increased BP
  • Decreased visual acuity
  • Arthralgias
  • Herpes viral infection
           

IV: intravenous, wk: week, TB: tuberculosis, CHF: congestive heart failure, Anti-TNF: Anti-tumour necrosis factor, HBV: hepatitis B virus, NMSC: non-melanoma skin cancer, CPK: Creatine phosphokinase